Comparison of sodium valporate and midazolam in children status epilepticus
Not Applicable
- Conditions
- status epilepticus.Status epilepticus
- Registration Number
- IRCT201206101808N4
- Lead Sponsor
- Research Center of Mazandaran University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Minimum age 3 month and maximum 14 years old ; Absence of renal or hepatic disfunction, shock, atrial or ventricular block ; No drug history of valproate or midazolam therapy in control of status epilepticus ; Normal range of CBC, BS,Ca, Na, K, BUN, Cr, SGOT, SGPT at beginning of treatment ; No control of status epilepticus with first line drugs such as diazepam, Phenytoin and Phenobarbital.
exclusion criteria: all children with acute or chronic liver disease ; all children with metabolic disease ; seizure in children with trauma ; all children with coagulation disfunction
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Status epilepticus treatment. Timepoint: before prevention and 24 hours after prevention. Method of measurement: questionarie.
- Secondary Outcome Measures
Name Time Method Complications of treatment. Timepoint: during first 72 hours of prevention. Method of measurement: questionarie.